Vaishalee P. Kenkre, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Kenkre is an assistant professor of medicine within the division of hematology/oncology at the UW School of Medicine and Public Health and at the William S. Middleton Memorial Veterans Hospital. She completed her medical degree at the University of Michigan Medical School in Ann Arbor, Michigan, and her postgraduate internship/residency training in Internal Medicine at the Tufts-New England Medical Center, in Boston, Massachusetts. Most recently, she completed her fellowship in Hematology/Oncology at the University of Chicago in Chicago, Illinois, in 2010.
Dr. Kenkre’s clinical interests are in hematology, specifically lymphoma and bone marrow transplantation. Her professional organization memberships include the American Society of Hematology, the American Society of Clinical Oncology and the American Medical Association.
Specialties
UW Health Clinics
Hospital Affiliation(s)
Languages Spoken
| English |
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
UW School of Medicine and Public Health
| Department of Medicine |
Professional Certifications and Education
| Board Certification |
Internal Medicine
|
| Fellowship |
University of Chicago Medical Center, Chicago, IL
|
| Residency |
Tufts-New England Medical Center, Boston, MA
|
| Internship |
Tufts-New England Medical Center, Boston, MA
|
| Medical School |
University of Michigan Medical School, Ann Arbor, MI, 2004
|
Procedures
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Programs & Conditions
| Research |
Dr. Kenkre is part of the Lymphoma Disease Oriented Work Group, which focuses on improving therapeutic options for patients with lymphoma. She is interested in drug development and novel therapeutics for patients with lymphoma and improving outcomes for those patients undergoing bone marrow transplantation. |
PubMed Articles
-
Kenkre VP Kahl BS .
What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma? Cancer J. 2012 Sep-Oct;18(5):383-9
[PubMed ID: 23006941]
-
Kenkre VP Kahl BS .
The future of B-cell lymphoma therapy: the B-cell receptor and its downstream pathways. Curr Hematol Malig Rep. 2012 Sep;7(3):216-20
[PubMed ID: 22688757]
-
Kenkre VP Kahl B .
Nodal marginal zone lymphoma: what do we really know? Oncology (Williston Park). 2012 Jan;26(1):108-9
[PubMed ID: 22393804]
-
Kenkre VP Long WL Eickhoff JC Blank JH McFarland TA Bottner W Rezazedeh H Werndli JE Bailey HH Kahl BS .
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network. Leuk Lymphoma. 2011 Sep;52(9):1675-80
[PubMed ID: 21864042]
-
Kenkre VP Long WL Eickhoff JC Blank JH McFarland TA Bottner W Rezazedeh H Werndli JE Bailey HH Kahl BS .
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network. Leuk Lymphoma. 2011 May 17;
[PubMed ID: 21585283]
-
Kenkre VP Kahl BS .
Follicular lymphoma: emerging therapeutic strategies. Expert Rev Hematol. 2010 Aug;3(4):485-95
[PubMed ID: 21083037]










